Bacterial infection in chronic obstructive pulmonary disease in 2000: A state-of-the-art review

Clinical Microbiology Reviews

Volumn 14, Issue 2, 2001, Pages 336-363

  Sethi, S ^a   Murphy, T F ^a  

^a VA WESTERN NEW YORK HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; BACTERIAL VACCINE; IRON; MUCIN;

ANTIBIOTIC THERAPY; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BRONCHOSCOPY; CAUSE OF DEATH; CHLAMYDOPHILA PNEUMONIAE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; DISEASE EXACERBATION; GRAM NEGATIVE BACTERIUM; HAEMOPHILUS PARAINFLUENZAE; HUMAN; IMMUNE RESPONSE; IRON TRANSPORT; LOWER RESPIRATORY TRACT INFECTION; MORAXELLA CATARRHALIS; MUCOCILIARY CLEARANCE; MUCUS SECRETION; POINT MUTATION; RESPIRATORY TRACT INFLAMMATION; REVIEW; STREPTOCOCCUS PNEUMONIAE; UNITED STATES;

ADULT; BACTERIAL INFECTIONS; CHILD; CHLAMYDOPHILA PNEUMONIAE; HAEMOPHILUS; HUMANS; LUNG DISEASES, OBSTRUCTIVE; MORAXELLA (BRANHAMELLA) CATARRHALIS; STREPTOCOCCUS PNEUMONIAE;

BACILLI; BACTERIA (MICROORGANISMS); CHLAMYDIA; CHLAMYDOPHILA PNEUMONIAE; HAEMOPHILUS PARAINFLUENZAE; MORAXELLA CATARRHALIS; NEGIBACTERIA; STREPTOCOCCUS PNEUMONIAE;

EID: 0035070005     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/CMR.14.2.336-363.2001     Document Type: Review

References (360)

1. Bacteria associated with obstructive pulmonary disease elaborate extracellular products that stimulate mucin secretion by explants of guinea pig airways
2. Mapping a protective epitope of the CopB outer membrane protein of Moraxella catarrhalis
3. Phenotypic effect of isogenic uspA1 and uspA2 mutations on Moraxella catarrhalis 035E
4. A protective epitope of Moraxella catarrhalis is encoded by two different genes
5. Expression of the CopB outer membrane protein by Moraxella catarrhalis is regulated by iron and affects iron acquisition from transferrin and lactoferrin
6. Fimbriae of Branhamella catarrhalis as possible mediators of adherence to pharyngeal epithelial cells
7. Expression of fimbriae and host response in Branhamella catarrhalis respiratory infections
8. Fimbriation, hemagglutination and adherence properties of fresh clinical isolates of Branhamella catarrhalis
9. Electron microscopic observation of Branhamella catarrhalis
10. Isolation of Branhamella catarrhalis from sputum and tracheal aspirate
11. Biological activity, of serum antibodies to nonacylated form of lipoprotein D of Haemophilus influenzae
12. Comparative safety and efficacy of sparfloxacin in the treatment of acute exacerbations of chronic obstructive pulmonary disease: A double-blind, randomized, parallel, multicentre study
13. Streptococcus pneumoniae: Virulence factors, pathogenesis, and vaccines
14. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease
15. Effects of human neutrophil elastase and Pseudomonas aeruginosa proteinases on human respiratory epithelium
16. Nasopharyngeal colonization during the first year of life
17. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease
18. Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines
19. Etiology, susceptibility, and treatment of acute bacterial exacerbations of complicated chronic bronchitis in the primary care setting: Ciprofloxacin 750 mg BID vs clarithromycin 500 mg BID
20. Localization of high-molecular-weight adhesion proteins of nontypeable Haemophilus infiuenzae by immunoelectron microscopy
21. Immunization with high-molecular-weight adhesion proteins of nontypeable Haemophilus infiuenzae modifies experimental otitis media in chinchillas
22. Cloning, expression, and DNA sequence analysis of the genes encoding nontypeable Haemophilus infiuenzae high-molecular-weight surface-exposed proteins related to filamentous hemagglutinin of Bordetelta pertussis
23. Outer membrane protein and biotype analysis of pathogenic nontypable Haemophilus influenzae
24. Genes encoding high-molecular-weight adhesion proteins of nontypeable Haemophilus influenzae are part of gene clusters
25. Identification of a second family of high-molecular-weight adhesion proteins expressed by nontypable Haemophilus infleunzae
26. Relation of birth weight and childhood respiratory infection to adult lung function and death from chronic obstructive airways disease
27. Comparison of the outer membrane proteins of 50 strains of Branhamella catarrhalis
28. The fate of the chronic bronchitic: A report of the ten-year follow-up in the Canadian Department of Veteran's Affairs coordinated study of chronic bronchitis
29. Chlamydia pneumoniae, strain TWAR, infection in patients with chronic obstructive pulmonary disease
30. Epidemiological typing of Moraxella catarrhalis by using DNA probes
31. Diversity of the P2 protein among nontypeable Haemophilus infiuenzae isolates
32. Analysis of isolates recovered from multiple sites of the nasopharynx of children colonized by nontypeable Haemophilus influenzae
33. Sequence heterogeneity of PsaA, a 37-kilodalton putative adhesin essential for virulence of Streptococcus pneumoniae
34. Additive attenuation of virulence of Streptococcus pneumoniae by mutation of the genes encoding pneumolysin and other putative pneumococcal virulence proteins
35. Effect of insertional inactivation of the genes encoding pneumolysin and autolysin on the virulence of Streptococcus pneumoniae type 3
36. Molecular cloning and characterization of outer membrane protein E of Moraxella (Branhamella) catarrhalis
37. Antigenic characterization and analysis of the human immune response to outer membrane protein E of Branhamella catarrhalis
38. Chlamydia pneumoniae infection in acute exacerbations of COPD
39. Characterization of Moraxella (Branhamella) catarrhalis lbpB, lpbA, and lactoferrin receptor orf3 isogenic mutants
40. Biochemical and immunological properties of lactoferrin binding proteins from Moraxella (Branhamella) catarrhalis
41. Branhamella (Moraxella) catarrhalis: Pathogenic significance in respiratory infections
42. Pneumococcal diversity: Considerations for new vaccine strategies with emphasis on pneumococcal surface protein A (PspA)
43. Characterization of noncapsulate Haemophilus infiuenzae by whole-cell polypeptide profiles, restriction endonuclease analysis, and rRNA gene restriction patterns
44. Ribotyping of strains of Moraxella (Branhamella) catarrhalis cultured from the nasopharynx and middle ear of children with otitis media
45. Bacterial colonization of distal airways in healthy subjects and chronic lung disease: A bronchoscopic study
46. Growth of Moraxella catarrhalis with human transferrin and lactoferrin: Expression of ironrepressible proteins without siderophore production
47. Lipooligosaccharide epitopes shared among gram-negative non-enteric mucosal pathogens
48. Role of the bacterial cell wall in middle ear inflammation caused by Streptococcus pneumoniae
49. Development of bactericidal antibody during Branhamella catarrhalis infection
50. Evaluation of bronchoscopic techniques for the diagnosis of nosocomial pneumonia
51. The levels and bactericidal capacity of antibodies directed against the UspA1 and UspA2 outer membrane proteins of Moraxella (Branhamella) catarrhalis in adults and children
52. Evaluation of purified UspA from Moraxella catarrhalis as a vaccine in a murine model after active immunization
53. Efficacy and safety of a 10-day course of 400 or 600 milligrams of grepafloxacin once daily for treatment of acute bacterial exacerbations of chronic bronchitis: Comparison with a 10-day course of 500 milligrams of ciprofloxacin twice daily
54. Randomized, double-blind study of ciprofloxacin and cefuroxime axetil for treatment of acute bacterial exacerbations of chronic bronchitis
55. Efficacy of oral ciprofioxacin vs clarithromycin for treatment of acute bacterial exacerbations of chronic bronchitis
56. Moraxella (Branhamella) catarrhalis: Clinical, microbiological and immunological features in lower respiratory tract infections
57. Moraxella (Branhamella) catarrhalis-induced experimental otitis media in the chinchilla
58. Oral immunization with killed Haemophilus influenzae for protection against acute bronchitis in chronic obstructive lung disease
59. Protection against recurrent acute bronchitis after oral immunization with killed Haemophilus influenzae
60. Specific immune response in the respiratory tract after administration of an oral polyvalent bacterial vaccine
61. Haemophilus influenzae release histamine and enhance histamine release from human bronchoalveolar cells
62. Endotoxin from Haemophilus influenzae enhances IgE-mediated and non-immunological histamine release
63. Host-microbe relationships in chronic respiratory infection
64. Characterization of the Moraxella catarrhalis uspA1 and uspA2 genes and their encoded products
65. The 100 kDa haem: Haemopexin-binding protein of Haemophilus influenzae: Structure and localization
66. A gene cluster involved in the utilization of both free heme and heme: Hemopexin by Haemophilus influenzae type B
67. The relations between structural changes in small airways and pulmonary-function tests
68. Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor
69. Relationship between colonial morphology and adherence of Streptococcus pneumoniae
70. Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine
71. Clinical effectiveness of levofloxacin in patients with acute purulent exacerbations of chronic bronchitis: The relationship with in vitro activity
72. Binding of Haemophilus influenzae to purified mucins from the human respiratory tract
73. Purification and characterization of Streptococcus pneumoniae palmitoylated pneumococcal surface adhesin A expressed in Escherichia coli
74. Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis
75. Carriage of respiratory tract pathogens and molecular epidemiology of Streptococcus pneumoniae colonization in healthy children attending day care centers in Lisbon, Portugal
76. Immunization with outer membrane protein P6 from nontypeable Haemophilus influenzae induces bactericidal antibody and affords protection in the chinchilla model of otitis media
77. Comparison of molecular epidemiological tools for Branhamella catarrhalis typing
78. Restriction fragment mapping of Branhamella catarrhalis: A new tool for studying the epidemiology of this middle ear pathogen
79. Severity of airflow limitation is associated with severity of airway inflammation in smokers
80. Isolation of Branhamella (Neisseria) catarrhalis from men with urethritis
81. Branhamella (Neisseria) catarrhalis systemic disease in humans
82. Animal models of otitis media: Other pathogens
83. Cloning and expression of the Moraxella catarrhalis lactoferrin receptor genes
84. Genetic analysis of the diversity in outer membrane protein P2 of non-encapsulated Haemophilus influenzae
85. Antigenic drift of non-encapsulated Haemophilus influenzae major outer membrane protein P2 in patients with chronic bronchitis is caused by point mutations
86. Fine mapping of outer membrane protein P2 antigenic sites which vary during persistent infection by Haemophilus influenzae
87. Structural studies of the O-polysaccharide from the lipopolysaccharide of Moraxella (Branhamella) catarrhalis serotype A (strain ATCC 25238)
88. Branhamella catarrhalis in children and adults: A study of prevalence, time of colonization, and association with upper and lower respiratory tract infections
89. Duration of nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae: Experiences from the South Swedish Pneumococcal Intervention Project
90. Infective exacerbations of chronic bronchitis: Relation between bacteriologic etiology and lung function
91. Otitis media in children. I. The systemic immune response to nontypeable Haemophilus influenzae
92. Relationship between nasopharyngeal colonization and the development of otitis media in children
93. Epidemiology of nasopharyngeal colonization with nontypeable Haemophilus influenzae in the first 2 years of life
94. Epidemiology of Moraxella catarrhalis in children during the first 2 years of life: Relationship to otitis media
95. Severe exacerbations of COPD patients: The role of pulmonary infections
96. Characterization of distal bronchial microflora during acute exacerbation of chronic bronchitis
97. Efficacy of pneumococcal vaccination in adults. A meta-analysis of randomized controlled trials
98. A 200 kDa protein is associated with haemagglutinating isolates of Moraxella (Branhamella) catarrhalis
99. Transmission electron microscopy studies of Moraxella (Branhamella) catarrhalis
100. Tissue culture adherence and haemagglutination characteristics of Moraxella (Branhamella) catarrhalis
101. The sequencing of the 80-kDa D15 protective surface antigen of Haemophilus influenzae
102. The natural history of chronic airflow obstruction
103. Comparative immunochemistry of lipopolysaccharides from Branhamella catarrhalis strains
104. Haemophilus influenzae resides and multiplies intracellularly in human adenoid tissue as demonstrated by in situ hybridization and bacterial viability assay
105. Persistence of nontypeable Haemophilus infiuenzae in adenoid macrophages: A putative colonization mechanism
106. Nontypeable Haemophilus influenzae: Pathogenesis and prevention
107. Limited contribution of emphysema in advanced chronic obstructive pulmonary disease
108. Dynamics of nasopharyngeal colonization by Streptococcus pneumoniae
109. Cloning, expression, and sequence analysis of the Haemophilus influenzae type B strain M43p+ pilin gene
110. Role of pili in Haemophilus influenzae adherence and colonization
111. Identification and characterization of genes encoding the human transferrin-binding proteins from Haemophilus influenzae
112. Characterization of transferrin binding proteins 1 and 2 in invasive type B and nontypeable strains of Haemophilus influenzae
113. The e (P4) outer membrane protein of Haemophilus influenzae: Biologic activity of anti-e serum and cloning and sequencing of the structural gene
114. Evaluation of mixtures of purified Haemophilus influenzae outer membrane proteins in protection against challenge with nontypeable H. influenzae in the chinchilla otitis media model
115. Haemophilus influenzae infections in patients with chronic obstructive pulmonary disease despite specific antibodies in serum and sputum
116. Changes in outer membrane proteins of nontypeable Haemophilus influenzae in patients with chronic obstructive pulmonary disease
117. Antigenic drift of Haemophilus influenzae in patients with chronic obstructive pulmonary disease
118. The relation between funding by the National Institutes of Health and the burden of disease
119. Synthesis and characterization of lipooligosaccharide-based conjugates as vaccine candidates for Moraxella (Branhamella) catarrhalis
120. Detoxified lipooligosaccharide from nontypeable Haemophilus influenzae conjugated to proteins confers protection against otitis media in chinchillas
121. Quantitation and biological properties of released and cell-bound lipooligosacchrides from nontypeable Haemophilus influenzae
122. Synthesis, characterization, and immunologic properties of detoxified lipooligosaccharide from nontypeable Haemophilus influenzae conjugated to proteins
123. Role of infection in chronic bronchitis
124. Bacterial flora of the respiratory tract in chronic bronchitis: Comparison of transtracheal, fiberbronchoscopic, and oropharyngeal sampling methods
125. Strain-specific and immunodominant surface epitopes of the P2 porin protein of nontypeable Haemophilus influenzae
126. Mapping of bactericidal epitopes on the P2 porin protein of nontypeable Haemophilus influenzae
127. Multicenter, randomized study comparing efficacy and safety of oral levofloxacin and cefaclor in treatment of acute bacterial exacerbations of chronic bronchitis
128. Branhamella catarrhalis respiratory infections
129. Chlamydia pneumoniae, asthma, and COPD: What is the evidence?
130. Immune enhancement of pulmonary clearance of nontypeable Haemophilus influenzae
131. The hbpA gene of Haemophilus influenzae type b encodes a heme-binding lipoprotein conserved among heme-dependent Haemophilus species
132. Induced sputum, eosinophilic bronchitis, and chronic obstructive pulmonary disease
133. Branhamella catarrhalis pathogenesis in SCID and SCID/beige mice
134. A major outer membrane protein of Moraxella catarrhalis is a target for antibodies that enhance pulmonary clearance of the pathogen in an animal model
135. A large, antigenically conserved protein on the surface of Moraxella catarrhalis is a target for protective antibodies
136. A mutation affecting expression of a major outer membrane protein of Moraxella catarrhalis alters serum resistance and survival in vivo
137. Spread of Streptococcus pneumoniae in families. I. Carriage rates and distribution of types
138. Structural determinants of processing and secretion of the Haemophilus influenzae Hap protein
139. The Haemophilus influenzae Hap serine protease promotes adherence and microcolony formation, potentiated by a soluble host protein
140. Neutrophil serine proteinases and defensins in chronic obstructive pulmonary disease: Effects on pulmonary epithelium
141. Tandem repeats of the tetramer 5'-CAAT-3' present in lic2A are required for phase variation but not lipopolysaccharide biosynthesis in Haemophilus influenzae
142. Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis
143. Evidence for in vivo expression of transferrin-binding proteins in Haemophilus influenzae type b
144. The lipopolysaccharide of Moraxella catarrhalis. Structural relationships and antigenic properties
145. Specific mucosal immunity and enhanced nasopharyngeal clearance of nontypeable Haemophilus influenzae after intranasal immunization with outer membrane protein P6 and cholera toxin
146. Evolution of the ventilatory capacity in chronic bronchitis
147. Outer membrane protein CD of Branhamella catarrhalis: Sequence conservation in strains recovered from the human respiratory tract
148. A prospective study of isolation of Moraxella catarrhalis in a hospital during the winter months
149. Pro: Antibiotics for chronic bronchitis with exacerbations
150. Editorial response: Predicting protection against encapsulated pathogens
151. Cloning of a DNA fragment encoding a heme-repressible hemoglobin-binding outer membrane protein from Haemophilus influenzae
152. Studies on the cellular and free lipopolysaccharides from Branhamella catarrhalis
153. Effect of pneumonia and whooping cough in childhood on adult lung function
154. Characterisation of non-capsulate Haemophilus influenzae by repetitive extragenic palindromic (REP)-PCR
155. Polymerase chain reaction-based strain characterization of noncapsulate Haemophilus influenzae
156. Comparison of the nasal bacterial floras in two groups of healthy subjects and in patients with acute maxillary sinusitis
157. Cloning and expression in Escherichia coli of LKP pilus genes from a nontypeable Haemophilus influenzae strain
158. Modification of otitis media in chinchillas rechallenged with nontypable Haemophilus influenzae and serological response to outer membrane antigens
159. Review of fungus-induced asthmatic reactions
160. Restriction fragment length polymorphism (RFLP) of genomic DNA of Moraxella (Branhamella) catarrhalis isolates in a hospital
161. Infection of primary human bronchial epithelial cells by Haemophilus influenzae: Macropinocytosis as a mechanism of airway epithelial cell entry
162. Bacterial-induced release of inflammatory mediators by bronchial epithelial cells
163. Basophil-bound IgE and serum IgE directed against Haemophilus influenzae and Streptococcus pneumoniae in patients with chronic bronchitis during acute exacerbations
164. Dynamics of respiratory tract colonization by Moraxella (Branhamella) catarrhalis in bronchiectasis
165. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation
166. Adhesion of nontypeable Haemophilus influenzae from blood and sputum to human tracheobronchial mucins and lactoferrin
167. Effects of oral and systemic immunization on nasopharyngeal clearance of nontypeable Haemophilus influenzae in BALB/c mice
168. Modulation of antigen-specific T and B cell responses influence bacterial clearance of non-typeable Haemophilus influenzae from the lung in a rat model
169. Potential of a novel protein, OMP26, from nontypeable Haemophilus influenzae to enhance pulmonary clearance in a rat model
170. Enhanced respiratory clearance of nontypeable Haemophilus influenzae following mucosal immunization with P6 in a rat model
171. Short-course cefuroxine axetil therapy in the treatment of acute exacerbations of chronic bronchitis
172. Randomized, double-blind study of grepafloxacin versus amoxycllin in patients with acute bacterial exacerbations of chronic bronchitis
173. Randomized, double-blind study of short-course (5 day) grepafloxacin versus 10 day clarithromycin in patients with acute bacterial exacerbations of chronic bronchitis
174. Bacteriologic flora of the lower respiratory tract
175. Bacterial colonization of the nasopharynx predicts very early onset and persistence of otitis media in Australian Aboriginal infants
176. Role of infection in the cause and course of chronic bronchitis and emphysema
177. Reduction in the incidence of acute bronchitis by an oral Haemophilus influenzae vaccine in patients with chronic bronchitis in the highlands of Papua New Guinea
178. Alpha 1-antitrypsin Pi-types in 965 COPD patients
179. Chlamydia pneumoniae - Specific circulating immune complexes in patients with chronic coronary heart disease
180. Cloning and expression of the Haemophilus influenzae transferrin receptor genes
181. The Haemophilus influenzae HtrA protein is a protective antigen
182. Epidemiological study of Streptococcus pneumoniae carriers in healthy primary-school children
183. Age-associated differences in immunoglobulin G1 (IgG1) and IgG2 subclass antibodies to pneumococcal polysaccharides following vaccination
184. Construction and characterization of Moraxella catarrhalis mutants defective in expression of transferrin receptors
185. Acute otitis media in Sweden. Role of Branhamella catarrhalis and the rationale for choice of antimicrobial therapy
186. Identification of an outer membrane protein involved in utilization of hemoglobin-haptoglobin complexes by nontypeable Haemophilus influenzae
187. Effect of immunization on pulmonary clearance of Moraxella catarrhalis in an animal model
188. Lipo-oligosaccharides (LOS) of mucosal pathogens: Molecular mimicry and host-modification of LOS
189. Lipooligosaccharides (LOS) of some Haemophilus species mimic human glycosphingolipids, and some LOS are sialylated
190. Pili (fimbriae) of Branhamella species
191. DNA restriction patterns produced by pulsed-field gel electrophoresis in Moraxella catarrhalis isolated from different geographical areas
192. Characterization of the lipopolysaccharide of Moraxella catarrhalis: Structural analysis of the lipid A from M. catarrhalis serotype A lipopolysaccharide
193. Characterization of an outer membrane protein of Moraxella catarrhalis
194. Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine
195. Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine
196. Identification of hifD and hifE in the pilus gene cluster of Haemophilus influenzae type b strain Eagan
197. A study of infective and other factors in exacerbations of chronic bronchitis
198. Characterisation of hospital isolates of Moraxella (Branhamella) catarrhalis by SDS-PAGE of whole-cell proteins, immunoblotting and restriction-endonuclease analysis
199. Increase in bronchopulmonary infection due to Branhamella catarrhalis
200. Isolation and characterization of two proteins from Moraxella catarrhalis that bear a common epitope
201. Definitions and classification of chronic bronchitis for clinical and epidemiological purposes: A report to the medical research council by their committee on the aetiology of chronic bronchitis
202. Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD
203. Immune response to Haemophilus parainfluenzae in patients with chronic obstructive lung disease
204. Chlamydia pneumoniae infection in patients with diffuse panbronchiolitis and COPD
205. New murine model of bronchopneumonia due to cell-bound Haemophilus influenzae
206. Acute purulent exacerbation of chronic obstructive pulmonary disease and Chlamydia pneumoniae infection
207. Multiple Haemophilus influenzae strains and strain variants coexist in the respiratory tract of patients with cystic fibrosis
208. Haemophilus influenzae in lung explants of patients with end-stage pulmonary disease
209. Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush
210. Use of molecular methods to characterize Moraxella catarrhalis strains in a suspected outbreak of nosocomial infection
211. Molecular cloning and sequence of the gene for outer membrane protein P5 of Haemophilus influenzae
212. Branhamella catarrhalis: Epidemiology, surface antigenic structure, and immune response
213. Branhamella catarrhalis: Epidemiological and clinical aspects of a human respiratory tract pathogen
214. Human bactericidal antibody response to outer membrane protein P2 of nontypeable Haemophilus influenzae
215. Antigenic characterization of the P6 protein of nontypable Haemophilus influenzae
216. Identification of a 16,600-dalton outer membrane protein on nontypable Haemophilus influenzae as a target for human serum bactericidal antibody
217. A subtyping system for nontypable Haemophilus influenzae based on outer-membrane proteins
218. Analysis of antigenic structure and human immune response to outer membrane protein CD of Moraxella catarrhalis
219. The major heat-modifiable outer membrane protein CD is highly conserved among strains of Branhamella catarrhalis
220. Bacterial infection in chronic obstructive pulmonary disease
221. Simultaneous respiratory tract colonization by multiple strains of nontypeable Haemophilus influenzae in chronic obstructive pulmonary disease: Implications for antibiotic therapy
222. Streptococcus pneumoniae
223. Pneumonia and acute febrile tracheobronchitis due to Haemophilus influenzae
224. Pneumococcal polysaccharide vaccine in young adults and older bronchitics: Determination of IgG responses by ELISA and the effect of adsorption of serum with non-type-specific cell wall polysaccharide
225. Genetic relationships of serologically nontypable and serotype b strains of Haemophilus influenzae
226. The transferrin binding protein B of Moraxella catarrhalis elicits bactericidal antibodies and is a potential vaccine antigen
227. Branhamella catarrhalis as a lower respiratory tract pathogen in patients with chronic lung disease
228. Con: Antibiotic use in exacerbations of chronic bronchitis
229. Bronchopulmonary infection due to Branhamella catarrhalis: 11 cases assessed by transtracheal puncture
230. High-molecular-weight surface-exposed proteins of Haemophilus influenzae mediate binding to macrophages
231. Epitope mapping of the outer membrane protein P5-homologous fimbrin adhesin of nontypeable Haemophilus influenzae
232. Pulmonary clearance and phagocytic cell response to normal pharyngeal flora
233. Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people
234. Occupational dust exposure and chronic obstructive pulmonary disease
235. Proteinase-antiproteinase imbalance in the pathogenesis of emphysema: The role of metalloproteinases in lung damage
236. Evaluation of restriction endonuclease analysis as an epidemiologic typing system for Branhamella catarrhalis
237. A nosocomial outbreak of Branhamella catarrhalis confirmed by restriction endonuclease analysis
238. IgE antibodies to bacteria in patients with bronchial asthma
239. Airways microbial flora in COPD patients in stable clinical conditions and during exacerbations: A bronchoscopic investigation
240. Helicobacter pylori and peptic ulcer disease
241. Esterase electrophoresis: A molecular tool for studying the epidemiology of Branhamella catarrhalis nosocomial infection
242. Incidence of Branhamella catarrhalis in the sputa of patients with chronic lung disease
243. Difference in structure between type b and nontypable Haemophilus influenzae populations
244. Application of multilocus enzyme gel electrophoresis to Haemophilus influenzae
245. Reactogenicity and immunogenicity of a protein-conjugated pneumococcal oligosaccharide vaccine in older adults
246. Opacity-associated protein A contributes to the binding of Haemophilus influenzae to Chang epithelial cells
247. Human milk lactoferrin inactivates two putative colonization factors expressed by Haemophilus influenzae
248. Antibody response in rabbits to serotype-specific determinants in lipopolysaccharides from Moraxella catarrhalis
249. Molecular determinants of the pathogenesis of disease due to non-typable Haemophilus influenzae
250. Interaction of pneumolysin-sufficient and -deficient isogenic variants of Streptococcus pneumoniae with human respiratory mucosa
251. The efficacy and safety of a new ciprofloxacin suspension compared with co-amoxiclav tablets in the treatment of acute exacerbations of chronic bronchitis
252. Interaction of notypable Haemophilus influenzae with human respiratory mucosa in vitro
253. Binding between outer membrane proteins of nontypeable Haemophilus influenzae and human nasopharyngeal mucin
254. Middle ear mucin glycoprotein: Purification and interaction with nontypable Haemophilus influenzae and Moraxella catarrhalis
255. The spread of multiply resistant Streptococcus pneumoniae at a day care center in Ohio
256. Lipoprotein e(P4) is essential for hemin uptake by Haemophilus influenzae
257. hgpB, a gene encoding a second Haemophilus influenzae hemoglobin- and hemoglobin-haptoglobin-binding protein
258. Identification of sequences in human transferrin that bind to the bacterial receptor protein, transferrin-binding protein B
259. Outbreak of Moraxella catarrhalis in a respiratory unit
260. Mechanism of adherence of Moraxella (Branhamella) catarrhalis
261. Tetracycline resistance in Moraxella (Branhamella) catarrhalis: Demonstration of two clonal outbreaks by using pulsed-field gel electrophoresis
262. Phenotypic variation of carbohydrate surface antigens and the pathogenesis of Haemophilus influenzae infections
263. Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity
264. Contribution of novel choline-binding proteins to adherence, colonization and immunogenicity of Streptococcus pneumoniae
265. Determination of antibody responses of elderly adults to all 23 capsular polysaccharides after pneumococcal vaccination
266. Pneumolysin in pneumococcal adherence and colonization
267. Magnitude, duration, quality, and function of pneumococcal vaccine responses in elderly adults
268. Airway eosinophilia in chronic bronchitis during exacerbations
269. Antibiotics in chronic obstructive pulmonary disease exacerbations: A meta-analysis
270. Subtyping of Haemophilus influenzae strains by pulsed-field gel electrophoresis
271. Turnover of nonencapsulated Haemophilus influenzae in the nasopharynges of otitis-prone children
272. Identification of a locus involved in the utilization of iron by Haemophilus influenzae
273. Characterization of an antigenically conserved heat-modifiable major outer membrane protein of Branhamella catarrhalis
274. Etiology and management of infections in chronic obstructive pulmonary disease
275. Serum antibodies to outer membrane proteins of Moraxella (Branhamella) catarrhalis in patients with bronchiectasis: Identification of OMP B1 as an important antigen
276. Airway inflammation and etiology of acute exacerbations of chronic bronchitis
277. Antigenic heterogeneity and molecular analysis of CopB of Moraxella (Branhamella) catarrhalis
278. Levofloxacin versus cefuroxime axetil in the treatment of acute exacerbation of chronic bronchitis: Results of a randomized, double-blind study
279. The relationship between pneumonia in early childhood and impaired lung function in late adult life
280. Birth weight, childhood lower respiratory tract infection, and adult lung function
281. Comparison of pneumococcal polysaccharide and CRM197 conjugated pneumococcal oligosaccharide vaccines in young and elderly adults
282. Bactericidal antibody and susceptibility to otitis media caused by nontypeable strains of Haemophilus influenzae
283. Molecular analysis of the P2 porin protein of nontypeable Haemophilus influenzae
284. Role of fimbriae expressed by nontypeable Haemophilus influenzae in pathogenesis of and protection against otitis media and relatedness of the fimbrin subunit to outer membrane protein A
285. Molecular characterization of pneumococcal nasopharynx isolates collected from children during their first 2 years of life
286. Branhamella catarrhalis infection imitating gonorrhea in a man
287. A 2-year survey of Branhamella catarrhalis in a general hospital
288. Carriage of multiple ribotypes of non-encapsulated Haemophilus influenzae in Aboriginal infants with otitis media
289. Low genetic diversity of Haemophilus influenzae type b compared to nonencapsulated H. influenzae in a population in which H. influenzae is highly endemic
290. Long PCR-ribotyping of nontypeable Haemophilus influenzae
291. Nonencapsulated Haemophilus influenzae in Aboriginal infants with otitis media: Prolonged carriage of P2 porin variants and evidence for horizontal P2 gene transfer
292. The definition of emphysema: Report of a national heart, lung and blood institute division of lung diseases workshop
293. Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease
294. Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation
295. The gene encoding protein D (hpd) is highly conserved among Haemophilus influenzae type b and nontypeable strains
296. Epidemiology of chronic mucus hypersecretion and obstructive airways disease
297. Pyruvate oxidase, as a determinant of virulence in Streptococcus pneumoniae
298. Monoclonal antibodies specific to porin of Haemophilus influenzae type b: Localization of their cognate epitopes and tests of their biological activities
299. Branhamella catarrhalis pneumonia. Report of two cases and review of the literature
300. Insights into the mechanism of respiratory tract colonization by nontypable Haemophilus influenzae
301. Influence of pili, fibrils, and capsule on in vitro adherence by Haemophilus influenzae type b
302. A Haemophilus influenzae IgA protease-like protein promotes intimate interaction with human epithelial cells
303. Haemophilus influenzae adheres to and enters cultured human epithelial cells
304. High-molecular-weight proteins of nontypable Haemophilus influenzae mediate attachment to human epithelial cells
305. Prevalence and distribution of the hmw and hia genes and the HMW and Hia adhesins among genetically diverse strains of nontypeable Haemophilus influenzae
306. Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD
307. Induction of emphysema and bronchial mucus cell hyperplasia by intratracheal instillation of lipopolysaccharide in the hamster
308. Role of infection in chronic bronchitis
309. A controlled trial of a killed Haemophilus influenzae vaccine for prevention of acute exacerbations of chronic bronchitis
310. Biotypes of Haemophilus parainfluenzae from the respiratory secretions in chronic bronchitis
311. Intraluminal airway inflammation in chronic bronchitis: Characterization and correlation with clinical parameters
312. Effect of lacto-N-neotetraose, asialoganglioside-GM1 and neuraminidase on adherence of otitis media-associated serotypes of Streptococcus pneumoniae to chinchilla tracheal epithelium
313. Opsonic antibodies to outer membrane protein P2 of nonencapsulated Haemophilus influenzae are strain specific
314. The induction of meningeal inflammation by components of the pneumococcal cell wall
315. Microbiological and clinical significance of a new property of defective lysis in clinical strains of pneumococci
316. Induction of pulmonary inflammation by components of the pneumococcal cell surface
317. Pathogenesis of pneumococcal infection
318. Pulmonary clearance of Moraxella catarrhalis in an animal model
319. Outer membrane porin protein of Haemophilus influenzae type b pore size and subunit structure
320. Genomic DNA fingerprinting of clinical Haemophilus influenzae isolates by polymerase chain reaction amplification: Comparison with major outer-membrane protein and restriction fragment length polymorphism
321. Serological typing of Branhamella catarrhalis strains on the basis of lipopolysaccharide antigens
322. Respiratory tract carrier rates of Moraxella (Branhamella) catarrhalis in adults and children and interpretation of the isolation of M. catarrhalis from sputum
323. Phase variation of H. influenzae fimbriae: Transcriptional control of two divergent genes through a variable combined promoter region
324. The fimbrial gene cluster of Haemophilus influenzae type b
325. Acute otitis media caused by Branhamella catarrhalis: Biology and therapy
326. Haemophilus influenzae localized in epithelial cell layers is shielded from antibiotics and antibody-mediated bactericidal activity
327. Paracytosis of Haemophilus influenzae through cell layers of NCI-H292 lung epithelial cells
328. Pulmonary clearance and phagocytic cell response in a murine model of Branhamella catarrhalis infection
329. Randomized comparative study of cefixime versus cephalexin in acute bacterial exacerbations of chronic bronchitis
330. Immune selection for antigenic drift of major outer membrane protein P2 of Haemophilus influenzae during persistence in subcutaneous tissue cages in rabbits
331. 20-year trends in the prevalence of asthma and chronic airflow obstruction in an HMO
332. Branhamella catarrhalis in respiratory secretions: Clinical correlation in 16 cases
333. Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease
334. Etiology of pneumonia and other common childhood infections requiring hospitalization and parenteral antimicrobial therapy
335. Comparison of randomly amplified polymorphic DNA analysis and pulsed-field gel electrophoresis for typing of Moraxella catarrhalis strains
336. An animal model demonstration of enhanced clearance of nontypable Haemophilus influenzae from the respiratory tract after antigen stimulation of gut-associated lymphoid tissue
337. Protection against non-typable Haemophilus influenzae following sensitization of gut associated lymphoid tissue: Role of specific antibody and phagocytes
338. Identification, cloning, and sequencing of the immunoglobulin A1 protease gene of Streptococcus pneumoniae
339. Interruption of capsule production in Streptococcus pneumoniae serotype 3 by insertion of transposon Tn916
340. Pneumococcal virulence factors and host immune responses to them
341. The oligosaccharide of Haemophilus influenzae
342. Identification and characterization of a cell envelope protein of Haemophilus influenzae contributing to phase variation in colony opacity and nasopharyngeal colonization
343. Relationship between phase variation in colony morphology, intrastrain variation in cell wall physiology, and nasopharyngeal colonization by Streptococcus pneumoniae
344. Branhamella catarrhalis pneumonia
345. Transcription of genes encoding iron and heme acquisition proteins of Haemophilus influenzae during acute otitis media
346. Use of antibiotics in preventing recurrent acute otitis media and in treating otitis media with effusion
347. The role of infection in COPD
348. The effect of bacterial products on ciliary functions
349. Five day moxifloxacin therapy compared with 7 day clarithromycin therapy for the treatment of acute exacerbations of chronic bronchitis
350. Effect of bacterial products on human ciliary function in vitro
351. Identification and characterization of an iron-regulated hemopexin receptor in Haemophilus influenzae type b
352. Affinity, conservation, and surface exposure of hemopexin-binding proteins in Haemophilus influenzae
353. Effect of lipid modification on the physicochemical, structural, antigenic and immunoprotective properties of Haemophilus influenzae outer membrane protein P6
354. The major outer membrane protein, CD, extracted from Moraxella (Branhamella) catarrhalis is a potential vaccine antigen that induces bactericidal antibodies
355. Importance of an immunodominant surface-exposed loop on outer membrane protein P2 of nontypeable Haemophilus influenzae
356. Human immune response to nontypeable Haemophilus influenzae in chronic bronchitis
357. Analysis of the immunological responses to transferrin and lactoferrin receptor proteins from Moraxella catarrhalis
358. Immunity to cross-reactive serotypes induced by pneumococcal conjugate vaccines in infants
359. Predisposing factors to bacterial colonization in chronic obstructive pulmonary disease